Navigation Links
IsoSleeve™ Source Delivery System

ProductsIsoSleeve™ Source Delivery System
Company C. R. Bard, Inc.
Item IsoSleeve™ Source Delivery System
Features 
  • Provided Sterile: Pre-loaded IsoSleeve™ needles are sterile and ready to use.
  • Pre-Loaded Needles: Each needle arrives custom loaded thereby decreasing pre-treatment preparation.
  • Ready To Use: Upon receipt, the product configuration allows for immediate use.
  • Reduce Handling: Spares unnecessary radiation exposure to clinical personnel.
  • Prevents Movement: Unique product design prevents movement of seeds and spacers until desired.
  • Tactile Feedback: Patented design feature allows for release verification of seeds and spacers.
  • Confirm Loading Pattern: The IsoSleeve™ delivery system design allows for easy viewing of seed and spacer pattern
  • Needle Labeling: Each IsoSleeve™ hub is labeled per the treatment plan.
  • Verification Photograph: With each shipment, a photographic record is provided of all loaded sleeves with labels documenting seed and spacer
  • Custom Loaded - patient Specific: Each custom-loaded needle corresponds directly to the patients treatment plan.
  • Needle Loading Pattern: Each needle can hold up to 7 seeds and 7 spacers.
  • Pre-Loaded Needle: IsoSleeve™ needle and obturator are shipped assembled and ready to use.
Description The IsoSleeve™ Source Delivery System incorporates a translucent inner sleeve into a proprietary design that provides the confidence that each needle load matches the proper load configuration prior to implant. Unlike other preloaded needle options, the IsoSleeve™ system allows for visual verification of the loading configuration giving you confidence that the needle load is correct. The IsoSleeve™ Source Delivery System is custom loaded for each patient and is delivered in a convenient package that allows an easy transfer to the sterile field for immediate use. With each order, Bard Brachytherapy provides a photographic record of each needle load, providing the confidence of knowing the location of each source.
Info C. R. Bard, Inc.
Customer Service: (800) 367-2273
Web site: http://www.crbard.com

Related medicine products :

1. Micro-Mini Fiber Optic Light - Source 100
2. 300XL Xenon Light Source
3. Xenon XL Light Source
4. Xenon Light Source
5. Xenon Light Source 175W With Turret
6. Storz 150W Light Source With Turret
7. Welch Allyn Wall/Desk Power Source for Binocular Indirect Ophthalmoscope
8. LX - Mini Light Source (Metal Halide) 25 Watt
9. AL1 180W Xenon Light Source
10. 8430W 300 Watt Xenon Light Source
11. 150 watt Halogen Light Source
Mac Pherson titanium tying forceps are ergonomic, very thin, angled with tying platforms. Round ergonomic design for great balance and feel. Fine platforms excellent for tying 10-0 suture.
Helveston tying forceps, standard with smooth jaws. For 4-0 to 6-0 sutures.
Tennant stainless steel tying forceps is extra delicate, straight with smooth jaws, 6 mm long platform, round handle with guide pin. For 9-0 to 11-0 sutures.
Sinskey tying forcep is very delicate with smooth jaws, curved. For 8-0 to 11-0 sutures.
Medicine Products:
(Date:8/20/2008)...PRNewswire/ -- Questex Media Group, Inc., a,global...nd owner of,American Spa and American Salon magazi...uty Shows, the International Esthetics, Cosmetics ...nt events today announced the,acquisition of SpaTr...ttp://www.SpaTrade.com ) and SpaExec ( http://ww...
(Date:8/20/2008)...surance market ranked 156 among fastest growing ... list, BETHESDA, Md., Aug. 20 /PRNewswire/ -- Int...ife insurance market, announced today that it has,...ted company in the US by,Inc. magazine. The compan...,fastest growing companies in America, having expe...
(Date:8/20/2008)...20 /PRNewswire/ -- WXYZ- TV/Channel 7 and The,Detr...ll give thousands of,Detroit metro area children a...DS" program. This year the program will be held Su...e Charles H. Wright Museum of African,American His... for Kids",has provided free immunizations to over...
(Date:8/20/2008)...wswire/ -- Fourteen physicians who have been,part ...they plan to enhance,the care and service they pro...re., "These are top-notch primary care physicians...ur organization," said Nick Turkal, M.D., Aurora,s...orward to working with,them to support their care ...
Breaking Medicine News(10 mins):Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:Integrity Capital Partners Ranked 2nd Fastest Growing Insurance Related Company in US by Inc. Magazine 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3Health News:Commonwealth Medical Group Physicians to Join Aurora Health Care 2
...lant Program, beset with administrative problems, ...t, The UCSD communicated its decision to relieve /...and kidney transplants, of his administrative resp... continue as a full-time surgeon and member of the...
...g to the Oxford University in England have reveale...ere to manage their own treatment and taught to sc...600 deaths could be avoided. Those patients who ch...n, according to the thickness of their blood run t...
...osquito-borne disease, chikungunya has affected ab...of Reunion. // This disease has no cure. Though ...n a stooped posture. The prevalence of the disea...s 45 000 new cases since mid-December. Philippe R...
...mmunologist at the U.S. Centers for Disease Contro... influenza virus this year have developed // resis...used for the treatment for flu infection. Drugs b...nd rimantadine are ineffectual for now and for the...
Other Medicine News:Health News:Resistant Influenza strains creates panic in US 2
(Date:8/18/2008)...swire-FirstCall/ -- Oramed,Pharmaceuticals, Inc. (...oper,of oral delivery systems, announced today tha...ss the Safety, Pharmacokinetics (PK) and,Pharmacod...Healthy,Subjects," has been chosen for presentatio...ean Association for the Study of Diabetes (EASD) i...
(Date:8/18/2008)...ently in Phase I -, PRINCETON, N.J. and SAN DIEGO..., a clinical stage biotechnology company committed...e-threatening and life-altering,infectious disease...1,772,B2 by the U.S. Patent and Trademark Office, ...rently in Phase I development for the treatment of...
(Date:8/15/2008)...-- Globus Medical, Inc., the largest,privately hel...announced,that the first FLEXUS(TM) Interspinous S...l Device Exemption ("IDE") recently granted to Glo..., The FLEXUS(TM) Spacer is placed with a unilater...imal disruption to the surrounding musculature,and...
(Date:8/14/2008)...e-FirstCall/ -- Pharmasset, Inc.,(Nasdaq: VRUS ),... to,discovering, developing and commercializing no...dited financial results for the third fiscal,quart...loss attributable to,common stockholders of $15.0 ...ter ended June 30, 2008, as compared to a net loss...
Breaking Medicine Technology:Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9ACSM and AMA Launch Exercise Is Medicine Program 5507 1ACSM and AMA Launch Exercise Is Medicine Program 5507 2ACSM and AMA Launch Exercise Is Medicine Program 5507 3Multi talented Entertainer Chris Brown Goes Back to School Taking on a Starring Role in the St Jude Math A Thon 28R 29 Video 5502 1Multi talented Entertainer Chris Brown Goes Back to School Taking on a Starring Role in the St Jude Math A Thon 28R 29 Video 5502 2IdentiGENs DNA TraceBack 28R 29 Receives USDA Process Verified Program Approval 5497 1IdentiGENs DNA TraceBack 28R 29 Receives USDA Process Verified Program Approval 5497 2IdentiGENs DNA TraceBack 28R 29 Receives USDA Process Verified Program Approval 5497 3Blood incompatible infant heart transplants safe may save more lives 5492 1Blood incompatible infant heart transplants safe may save more lives 5492 2
...n Colorectal Cancer,and in Hormone-Refractory Pros..., June 01, 2007,/PRNewswire-FirstCall/ -- Poniard ...y focused on oncology, today announced,promising r...e 1,dose-escalating trials of picoplatin, a new ge...atment of metastatic colorectal cancer,(CRC) and m...
...Pharmaceuticals Inc.,(TSX: TLN) announced today th...rial investigating ECO-4601 in advanced cancer,pat...e American,Society of Clinical Oncology (ASCO) Ann...ose escalation portion of the study, 14,patients (...glioma), that had completed and not responded to t...
Other Medicine Technology:Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 2Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 3Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 4Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 5Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 6Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 2Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 3